Des Jarlais

1.1k total citations
14 papers, 681 citations indexed

About

Des Jarlais is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Des Jarlais has authored 14 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 2 papers in Pharmacology. Recurrent topics in Des Jarlais's work include HIV, Drug Use, Sexual Risk (5 papers), HIV/AIDS Research and Interventions (4 papers) and Alcoholism and Thiamine Deficiency (2 papers). Des Jarlais is often cited by papers focused on HIV, Drug Use, Sexual Risk (5 papers), HIV/AIDS Research and Interventions (4 papers) and Alcoholism and Thiamine Deficiency (2 papers). Des Jarlais collaborates with scholars based in United States, China and Malaysia. Des Jarlais's co-authors include Samuel R. Friedman, David Purchase, Holly Hagan, M J Alter, Stanley R. Yancovitz, Nurhidayat Nurhidayat, Zhou, Richard S. Schottenfeld, Jih‐Heng Li and Michael Marmor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and American Journal of Public Health.

In The Last Decade

Des Jarlais

11 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Des Jarlais United States 8 482 343 137 118 111 14 681
Steven R. Truax United States 5 296 0.6× 224 0.7× 55 0.4× 37 0.3× 117 1.1× 8 410
Robert Maslansky United States 10 318 0.7× 213 0.6× 68 0.5× 108 0.9× 112 1.0× 18 570
Atul Ambekar India 9 624 1.3× 379 1.1× 60 0.4× 267 2.3× 57 0.5× 30 763
John Wenston United States 8 344 0.7× 238 0.7× 68 0.5× 95 0.8× 126 1.1× 9 640
Patrizio De Longis Italy 9 205 0.4× 684 2.0× 306 2.2× 71 0.6× 116 1.0× 10 827
Yolanda Serrano United States 6 572 1.2× 359 1.0× 75 0.5× 100 0.8× 330 3.0× 7 781
Blanche Frank United States 10 270 0.6× 116 0.3× 36 0.3× 120 1.0× 104 0.9× 18 408
Crescenzo Maria Izzo Italy 6 201 0.4× 546 1.6× 193 1.4× 76 0.6× 105 0.9× 9 710
Catherine Quillet France 12 300 0.6× 355 1.0× 146 1.1× 49 0.4× 34 0.3× 34 469
Meiyang Gao China 14 264 0.5× 244 0.7× 69 0.5× 30 0.3× 63 0.6× 35 431

Countries citing papers authored by Des Jarlais

Since Specialization
Citations

This map shows the geographic impact of Des Jarlais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Des Jarlais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Des Jarlais more than expected).

Fields of papers citing papers by Des Jarlais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Des Jarlais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Des Jarlais. The network helps show where Des Jarlais may publish in the future.

Co-authorship network of co-authors of Des Jarlais

This figure shows the co-authorship network connecting the top 25 collaborators of Des Jarlais. A scholar is included among the top collaborators of Des Jarlais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Des Jarlais. Des Jarlais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Li, Jih‐Heng, et al.. (2011). To use or not to use: an update on licit and illicit ketamine use. SHILAP Revista de lepidopterología. 2. 11–11. 97 indexed citations
3.
Quaglio, Gianluca, Cristian Pattaro, Gilberto Gerra, et al.. (2010). Buprenorphine in maintanance treatment: experience among italian physician in drug addiction centers.. 3(19). 1–9. 1 indexed citations
4.
Perlman, David C., et al.. (1995). Tuberculosis in Drug Users. Clinical Infectious Diseases. 21(5). 1253–1264. 51 indexed citations
5.
Hagan, Holly, Des Jarlais, Samuel R. Friedman, David Purchase, & M J Alter. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.. American Journal of Public Health. 85(11). 1531–1537. 198 indexed citations
6.
Jarlais, Des & Manuel Carballo. (1993). HIV and injecting drug use.. PubMed. 4(2). 5, 11–2. 5 indexed citations
7.
Vermund, Sten H., Terri Creagh-Kirk, Elizabeth Andrews, et al.. (1991). National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.. PubMed. 4(4). 392–401. 43 indexed citations
8.
Jarlais, Des & Samuel R. Friedman. (1988). Gender differences in response to HIV infection.. PubMed. 44. 159–63. 5 indexed citations
9.
Jarlais, Des, et al.. (1987). HIV infection among intravenous drug users: epidemiology and risk reduction.. PubMed. 1(2). 67–76. 168 indexed citations
10.
Jarlais, Des, Michael Marmor, Helen S. Cohen, et al.. (1987). Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.. PubMed. 1(2). 105–11. 90 indexed citations
11.
Mj, Kreek, et al.. (1986). Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: therapeutic, historical, and ethical aspects.. PubMed. 67. 318–20. 11 indexed citations
12.
Jarlais, Des, et al.. (1985). Medical maintenance feasibility study.. PubMed. 58. 101–10. 12 indexed citations
13.
Jarlais, Des, et al.. (1977). The traditional Japanese dwelling in Hawaii.
14.
Jarlais, Des, et al.. (1976). Rules and rule breaking in a therapeutic community.. PubMed. 2(4). 627–41.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026